Science
-
Party Drug No More? How Ecstacy Could Be the New Cure for PTSD
The US Food and Drug Administration has given its approval on Tuesday for a large-scale, Phase III clinical trial of MDMA, more popularly known as Ecstasy, as a prescription medication, potentially for the treatment of post-traumatic stress disorder, a common condition in soldiers sent to war-stricken countries, such as Iraq and Afghanistan.
Latest Research Articles
-
Ecstacy Could Become the New Face of PTSD Treatments
-
Ice Balloons: NASA Begins Antarctica Balloon Flight Campaign
-
Over 50 Trillion Kilograms of Carbon Will Be Released From Soil if Climate Change Doesn't Stop
-
Dronebusters: Drone Gun Can Take Down Drones with Radio Waves
-
Human Embryo Experiment Makes 3-Parent IVF Safer, Sets Stage for Human Trials
-
Human Ancestor 'Lucy' Mostly Climbed Trees Than Walked
-
Bacteria Causing Aging Found? Scientists Believe Aging Should Be Classified as a Disease
-
Want Faster Electronics? Researchers Use Light in Transistors
-
ADHD Drug Amphetamine Can Improve Endurance, New Study Says
-
Game Changer: Scientists Develop New Technique to Test Antibiotic Efficiency
-
Scientists Create First 'Water-Wave Laser' That Can Be Used in New Drug Therapies
-
How to Win NASA's $30,000 'Space Poop' Challenge